SKU: 0622ATC

LK-2 Human Lung Epithelial Cells

Tumor Cell Lines > Lung Cancer Cell Lines

Product Type: Human Lung Cancer Cell Lines

Species: Human

Cell Type: Epithelial Cells

Source Organ: Lung

Delivery and Shipping

Ship on dry ice.

Cell Name: LK-2

Squamous cell carcinoma. Low molecular weight thiol protease inhibitor-producing.

Description

LK-2 is a human lung squamous cell carcinoma cell line that was originally derived from a 74-year-old male patient with squamous cell carcinoma of the lung. LK-2 exhibits epithelial-like morphology and adherent culture properties. This cell line displays features of squamous cell carcinoma and is known to produce low-molecular-weight thiol protease inhibitors.
Product Name

LK-2
Product Type

Human Lung Cancer Cell Lines
Species

Human
Cell Type

Epithelial-like
Source Organ

Lung
Product Type

Human Lung Cancer Cell Lines
Growth Conditions

37 °C, 5% CO2
Application

Squamous cell carcinoma (SCC) research advances cancer biology by investigating molecular mechanisms, genetic mutations, signaling pathways, and immune responses underlying its pathogenesis. It enables biomarker identification for diagnostic/prognostic tools to improve early intervention and guides therapeutic approaches through targeted drug discovery that selectively exploits cancer cell vulnerabilities. This work facilitates precision medicine by correlating genetic alterations with treatments and drives immunotherapy development through tumor microenvironment analysis. SCC studies further inform clinical trial designs for novel therapies while enhancing public health education on risk factors and prevention strategies.
Size/Quantity

1 vial
Recommended Medium And Supplement

RPMI 1640 + 10% FBS
Shipping Conditions

Dry Ice
Storage

Liquid Nitrogen
Biosafety Level

1

Payment methods

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Tell us what you need and our team will get back to you with pricing and availability.